PTPRC and cancer: We identified immune cells as CD45+ cells, B16F10 cancer cells (herein “B16”) as CD45− side scatter (SSC)hi cells, and other non-immune tumor infiltrating cells (here defined as stroma) as CD45−SSClo cells by flow cytometry.